Triple

T22690548
Position Surface form Disambiguated ID Type / Status
Subject LOXO-292 E561037 entity
Predicate hasClinicalTrialIdentifier P149281 FINISHED
Object LIBRETTO-321 NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: LIBRETTO-321 | Statement: [LOXO-292, hasClinicalTrialIdentifier, LIBRETTO-321]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: LIBRETTO-321
Context triple: [LOXO-292, hasClinicalTrialIdentifier, LIBRETTO-321]
  • A. LIBRETTO-121
    LIBRETTO-121 is a clinical trial evaluating the investigational RET inhibitor LOXO-292 (selpercatinib) in patients with cancers driven by RET gene alterations.
  • B. Liber AL
    Liber AL is the central sacred text of Thelema, a mystical and philosophical system founded by Aleister Crowley in the early 20th century.
  • C. Liber
    Liber is an ancient Roman god associated with viticulture, fertility, and freedom, often identified with the Greek god Dionysus.
  • D. Libu
    Libu were an ancient Libyan tribal group from North Africa known for their interactions and conflicts with pharaonic Egypt.
  • E. Biblioteca Breve
    Biblioteca Breve is a renowned literary imprint known for publishing influential works of contemporary Spanish and Latin American fiction.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: LIBRETTO-321
Target entity description: LIBRETTO-321 is a clinical trial evaluating the targeted cancer therapy LOXO-292 (selpercatinib) in patients with tumors driven by RET gene alterations.
  • A. LIBRETTO-121 chosen
    LIBRETTO-121 is a clinical trial evaluating the investigational RET inhibitor LOXO-292 (selpercatinib) in patients with cancers driven by RET gene alterations.
  • B. Liber AL
    Liber AL is the central sacred text of Thelema, a mystical and philosophical system founded by Aleister Crowley in the early 20th century.
  • C. Liber
    Liber is an ancient Roman god associated with viticulture, fertility, and freedom, often identified with the Greek god Dionysus.
  • D. Libu
    Libu were an ancient Libyan tribal group from North Africa known for their interactions and conflicts with pharaonic Egypt.
  • E. Biblioteca Breve
    Biblioteca Breve is a renowned literary imprint known for publishing influential works of contemporary Spanish and Latin American fiction.
  • F. None of above.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2454d71b48190a1f80af9f82b6fcf completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1789a1fd08190bce5fa0babe695d3 completed April 29, 2026, 3:18 a.m.
Created at: April 17, 2026, 3:13 p.m.